Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Sunitinib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sunitinib 12.5mg capsules
0801050AMAAAAAA
|
Sunitinib | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sunitinib 25mg capsules
0801050AMAAABAB
|
Sunitinib | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sunitinib 37.5mg capsules
0801050AMAAADAD
|
Sunitinib | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sunitinib 50mg capsules
0801050AMAAACAC
|
Sunitinib | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sutent 12.5mg capsules
0801050AMBBAAAA
|
Sutent | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sutent 25mg capsules
0801050AMBBABAB
|
Sutent | Sunitinib | Malignant Disease and Immunosuppression | No data available |
|
Sutent 50mg capsules
0801050AMBBACAC
|
Sutent | Sunitinib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.